MORGAN STANLEY PLC/CALL/CVS HEALTH/109/0.1/20.12.24 Stock

Warrant

DE000MB33TT9

Real-time Bid/Ask 08:16:29 2024-06-27 am EDT
0.022 EUR / 0.04 EUR +10.71% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/109/0.1/20.12.24
1 month+40.00%
3 months-59.42%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-27 0.025 -10.71%
24-06-26 0.028 +3.70%
24-06-25 0.027 -6.90%
24-06-24 0.029 0.00%
24-06-21 0.029 0.00%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 03:22 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33TT
ISINDE000MB33TT9
Date issued 2023-02-01
Strike 109 $
Maturity 2024-12-20 (176 Days)
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.63
Lowest since issue 0.013
Spread 0.018
Spread %45.00%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus